Kanglaite injection enhances the efficacy of cisplatin in suppressing HCC cells by inhibiting the CKLF1-mediated NF-κB pathway and regulating transporter-mediated drug efflux [66]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.